Abeloff, M. D., Armitage, J. O., Lichter, A. S., & Niederhuber, J. E.
(Eds.). (2000). Clinical Oncology (2nd ed.). New York: Churchill Livingstone.
Ahles, T., Saykin, A., Furstenberg, C., & et.al. (2002). Neuropsychologic impact
of standard-dose systemic chemotherapy in long-term survivors of breast cancer and
lymphoma. Journal of Clinical Oncology, 20(2), 485-493.
Albright, A., & Valente, S. (1998). Depression and suicide. In R. Carroll-Johnson,
et. al. (Ed.), Psychosocial nursing care along the cancer continuum (pp. 153-165).
Pittsburgh, PA: Oncology Nursing Press.
American Cancer Society: Sexuality and cancer for the woman who has cancer and her
partner. (2001) Publication #4657.
American Cancer Society: Sexuality and cancer for the man who has cancer and his
partner. (2001) Publication #4658.
Berg, D. (2001). Diarrhea. In J. M. Yasko (Ed.), Nursing Management of Symptoms
Associated with Chemotherapy (5th ed., pp. 109-130). West Conshohocken, PA: Menicus
Health Care Communication.
Boyle, D. (2001). Psychosocial issues. In E. Lin (Ed.), Advanced practice in oncology
nursing (pp. 213-232). Philadelphia: WB Saunders.
Brietbart, W. (2002). Depression. In K. Kuebler & P. Esper (Eds.), Palliative
practice from a-z (pp. 85-88). Pittsburgh, PA: Oncology Nursing Press Press.
Briscoe, K. (1989). Optimal management of nausea and vomiting in clinical oncology.
Oncology, 3(8 Supplement), 11-15.
Carroll-Johnson, R. M., Gorman, L. M., & Bush, N. J. (Eds.). (1998). Anxiety
and the cancer experience. Pittsburgh, PA: Oncology Nursing Press.
The Cleveland Clinic Foundation. For your information: home instructions for management
of nausea. (1995).
Conrad KJ. (2001). Cutaneous reactions. In Yasko JM (Ed.), Nursing Management of
Symptoms Associated with Chemotherapy (5th ed.).
Constipation protocol. (1995). Cleveland Clinic Foundation: Triage protocols for
the oncology nurse help line program.
Cope, D. (2001). Exploring the relationship between cognitive function and chemotherapy.
Clinical Journal of Oncology Nursing, 5(5), 233-234.
Costabel, U., & King, T. E. (2001). International consensus statement on idiopathic
pulmonary fibrosis. European Respiratory Journal, 17(2), 163-167.
Couillard-Getreuer DL, & Lutgen Heery M. (1994). Protective mechanisms: skin.
In Gross J & Libey Johnson B (Eds.), Handbook of Oncology Nursing (2nd ed.,
pp. 421-463). Boston, MA: Jones & Bartlett.
Fabian, C. J., Molina, R., & Slavik, M. (1990). Pyridoxine therapy for palmar-plantar
erythrodysesthesia associated with continuous 5-fluorouracil infusion. Investigational
New Drugs, 8(1), 57-63.
Gacsedi, R. A. (2002). Massage therapy for patients with cancer. Clinical Journal
of Oncology Nursing, 6(1), 52-54.
Gordon, K. B., Tajuddin, A., & Guitart, J. (1995). Hand-foot syndrome associated
with liposome-encapsulated doxorubicin therapy. Cancer, 75(8), 2169-2173.
Gross, J., & Johnson, B. L. (Eds.). (1998). Handbook of oncology nursing. London:
Jones and Bartlett Publishers International Publications.
Harsch, R. (2002). Preventing infection during your chemotherapy treatment. Georgia-Pacific
health smart institute association for professionals in infection control and epidemiology.
Hoffman, R., Benz, E. J., Shattil, S. J., Furie, B., Cohen, H. J., Silberstein,
L. E., et al. (Eds.). (2000). Hematology: basic principles and practice, 3rd edition.
New York: Churchill Livingstone.
Hussein MA, Wood L, Saluan MA, & et al. (1998). Efficacy of pyridoxine to ameliorate
cutaneous toxicity associated with doxil abstract # 4143. Paper presented at the
American Society of Hematology.
Itano, J., & Taoka, K. (Eds.). (1998). Core curriculum for oncology nursing
(3rd ed.). Philadelphia PA: W.B Saunders Co.
Karlowicz, K. (Ed.). (1995). Urologic nursing; principles and practice. Philadelphia,
PA: WB Saunders Co.
King, T. E., et. al. (2000). Idiopathic pulmonary fibrosis: diagnosis and treatment.
International consensus statement. American Thoracic Society (ATS) and the European
Respiratory Society (ERS). American Journal of respiratory critical care medicine,
161(2), 646-664.
Lee A, & Thomson J. (1999). Drug-induced skin reactions. Pharmaceutical Journal,
262, 357-362.
Lubejko, B. G., & Sartorius, S. E. (1993). Nursing considerations in paclitaxel
(Taxol®) administration. Seminars in Oncology, 20(4, Supplement 3), 26-30.
Lynch, M. P. (2000). Depression in the cancer patient. Nurse Practioner SIG(Nov),
4-5.
Malpas, J., Bergsagel, D., & Kyle, A. (Eds.). (1998). Myeloma biology and management
(2nd ed.). New York: Oxford university press.
MD Consult: A resource for clinicians. (2003, 1/2/2003). Retrieved May 8, 2003,
from http://home.mdconsult.com
Meek, P. M., et. al. (1999). Dyspnea. Mechanisms, assessment and management: a consensus
statement. American Thoracic Society. American Journal of respiratory critical care
medicine, 159(1), 321-340.
Merideth, P. V., & Horan, N. M. (Eds.). (2000). Adult primary care. Philadelphia:
WB Saunders Co.
Mortimer J, & Anderson I. (1990). Weekly fluorouracil and high-dose leucovorin:
efficacy and treatment of cutaneous toxicity. Cancer Chemotherapy and Pharmacology,
26, 449-452.
Our bodies, ourselves for the new century: A book by and for women (Comprehensive
book on women's health and sexuality) Boston Women's Health Book Collective. (1998).
New York: Touchstone Books.
PEG-INTRON®
(peginterferon alfa-2b) Powder for Injection. (2002). Retrieved May 9, 2003, from
http://www.pegintron.com/
Pike, K. (2001). Hand-foot syndrome. Oncology Nursing Forum, 28(10), 1519-1520.
Pisarnthanarax, N., & Duvic M. (2002). Dermatologic complications of cancer
chemotherapy. In JF Holland & E. Frei (Eds.), Cancer Medicine (pp. 2271-2278).
Hamilton, Ontario: BC Decker Inc.
PM Meek, & et. al. (1999). Dyspnea: mechanisms, assessment and management: a
consensus statement American Thoracic Society. American Journal of Respiratory Critical
Care Medicine, 159(1), 321-340.
Preparing for your treatment with BEXXAR® : A patient's guide to the BEXXAR® therapeutic
regimen for non-Hodgkin's lymphoma, Patient resource pamphlet. (2003). The
GlaxoSmithKline Group of Companies and Corixa Corporation.
Questions and Answers About Taxotere®for Injection Concentrate. (2002). Retrieved
May 9, 2003, from http://www.aventis-us.com.
Seller, R. (Ed.). (2000). Differential diagnosis of common complaints. Philadelphia:
WB Saunders Co.
Schover, L. R. (1997). Sexuality and fertility after cancer. New York: John Wiley
& Sons.
Schwartz, S., & Plawecki, H. (2002). Consequences of chemotherapy on the sexuality
of patients with lung cancer. Clinical Journal of Oncology Nursing, 6(4).
Self Help for Hard of Hearing People. (2002, 4/11/03). Retrieved May 9, 2003, from
http://www.shhh.org
Shelton, B. K., & Turnbough, L. (1996). Flu-like syndrome. In S. Groenwald (Ed.),
Cancer Symptom Management (pp. 59-71). Boston, MA: Jones and Bartlett.
Sherry VW. (2001). Taste alterations among patients with cancer. Clinical Journal
of Oncology Nursing, 6(2), 73-77.
Skeel, R. (Ed.). (1999). Handbook of cancer chemotherapy. Philadelphia: Lippincott,
Williams & Wilkins.
Specific Information for the Health Professional. (2003, May 7, 2003). Retrieved
May 8, 2003, from http://www.atsdr.cdc.gov
Spencer, P. (2002). Anxiety. In K. Kuebler & P. Esper (Eds.), Palliative practice
from a - z (pp. 23-26). Pittsburgh, PA: ONS Press.
St Marie, B. (2000). Anxiety. In D. H. Camp-Sorrell, R, (Ed.), Clinical manual for
the oncology practice nurse (pp. 133-134). Pittsburgh, PA: ONS Press.
Stoller, J. K., Ahmad, M., & Longworth, D. L. (Eds.). (2002). Intensive review
of internal medicine (3rd ed.). Philadelphia PA: Lippincott, Williams and Wilkins.
Tierney, L. M., McPhee, S. J., & Papadakis, M. A. (Eds.). (2001). Current medical
diagnosis and treatment (40th ed.). Stanford, CT: Appleton and Lange.
Triozzi, P., & Laszlo, J. (1990). Recent advances in the control of nausea and
vomiting. Primary Care & Cancer.
Uphold, C. R., & Graham, M. V. (Eds.). (1999). Clinical guidelines in adult
health (5th ed.). Gainesville FL: Barmarrae Books.
USPHS/IDSA Guidelines for the prevention of opportunistic infections in persons
infected with human immunodeficiency virus: a summary. (1995). MMWR, 44, RR-8.
Uthman, E. O. (1996, 9/16/2001). Interpretation of lab test profiles. Retrieved
May 8, 2003, from http://mededucation.bjmu.edu.cn.
Viale, P., & Mister, S. (2001). Utilization of medical-assistance programs for
medically uninsured patients: one public teaching hospital's experience. Clinical
Journal of Oncology Nursing, 5(6), 247-252.
Voss, M. A. B., & Wilkes, G. M. (1999). Neurotoxicities. American Journal of
Nursing, Oncology Nursing Update, 20-23.
Weihofen, D., & Marino, C. (1998). The cancer survival cookbook. New York: John
Wiley & Sons.
Weiss PA, & O'Rourke M. (1999). Cutaneous manifestations of cancer and cancer
treatment. American Journal of Nursing (April Supplement), 13-16.
Wilkes, G. M. (1996). Neurological disturbances. In S. Groenwald (Ed.), Cancer Symptom
Management (pp. 323-330). Boston, MA: Jones and Bartlett.
Wilkes, G. M., Ingwersen, & Barton-Burke (Eds.). (2002). Oncology Nursing Drug
Handbook. Boston, MA: Jones and Bartlett.
Wilkinson, K. (2001). Irinotecan hydrochloride. Clinical Journal of Oncology Nursing,
5(4), 179.
Woodruff, R. (1997). Gastrointestinal. In Pharmacia & Upjohn (Eds.), Symptom
control in advanced cancer (pp. 18-21). Melbourne.
Yarbro, C. H., Frogge, M. H., Goodman, M., & Groenwald, S. L. (Eds.). (1999).
Cancer symptom management (5th ed.). Boston, MA: Jones and Barlett.
Zilbergeld, B. (1999). The new male sexuality: The truth about men, sex and pleasure.
New York: Bantam Books.
Clinical Trials
Search Cancer Clinical Trials
Carefully controlled studies to research the safety and benefits of new drugs and therapies.